18889881171
Kalkine 0
countryflagUS

BioNeutra Global Corporation

Consumer Defensive US BGACF

0.067USD
-(-%)

Last update at 2025-05-21T20:00:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.00350.07
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap3.11M
  • Volume4943
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.13M
  • Revenue TTM10.34M
  • Revenue Per Share TTM0.24
  • Gross Profit TTM 2.89M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -2.10758M -2.92148M -2.82964M -3.77178M -13.02032M
Minority interest - - - - -
Net income -2.10758M -2.92148M -2.82964M -3.70698M -12.44331M
Selling general administrative 3.73M 3.78M 4.49M 5.43M 8.38M
Selling and marketing expenses 0.39M 0.14M 0.43M 0.36M 0.81M
Gross profit 4.14M 2.35M 2.89M 3.94M 0.64M
Reconciled depreciation 1.07M 1.11M 1.32M 1.84M 2.32M
Ebit -1.41035M -2.47116M -2.43900M -3.33863M -9.83115M
Ebitda -0.35191M -1.36035M -1.11518M -1.49774M -7.50624M
Depreciation and amortization 1.06M 1.11M 1.32M 1.84M 2.32M
Non operating income net other - - - - -
Operating income -0.89181M -2.46662M -2.35197M -3.02212M -9.83115M
Other operating expenses 12.27M 15.86M 17.76M 27.14M 47.53M
Interest expense 0.70M 0.45M 0.39M 0.43M 0.60M
Tax provision 0.00000M 0.00000M -0.00008M -0.06480M -0.57701M
Interest income 0.01M 0.00011M 0.00327M 0.00417M 0.00179M
Net interest income -0.64586M -0.45021M -0.38737M -0.42899M -0.59447M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.10011M 0.45M 0.39M -0.06480M -0.57701M
Total revenue 11.38M 13.39M 15.40M 24.12M 37.70M
Total operating expenses 4.14M 4.82M 5.25M 6.97M 10.47M
Cost of revenue 7.24M 11.04M 12.51M 20.17M 37.06M
Total other income expense net -1.21577M -0.50306M -0.47440M -0.74549M -2.59292M
Discontinued operations - - - - -
Net income from continuing ops -4.70969M -2.92148M -2.82964M -3.70698M -12.44331M
Net income applicable to common shares - - -2.82964M -3.70698M -12.44331M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 15.77M 19.78M 21.08M 23.68M 34.02M
Intangible assets 0.32M 0.43M 0.40M 0.64M 1.13M
Earning assets - - - - -
Other current assets 0.57M - - - -
Total liab 21.96M 23.54M 22.12M 22.98M 29.27M
Total stockholder equity -6.19396M -3.75575M -1.03385M 0.70M 4.75M
Deferred long term liab - - - - -
Other current liab 1.39M - 1.10M 1.12M 1.37M
Common stock 7.55M - 7.55M 7.55M 7.55M
Capital stock 7.55M 7.55M 7.55M 7.55M 7.55M
Retained earnings -16.05307M -13.94549M -11.02401M -8.19437M -4.48739M
Other liab - - - 0.03M 0.06M
Good will - - - - -
Other assets - - - - -
Cash 1.89M 0.72M 0.84M 0.93M 0.52M
Cash and equivalents - - - - -
Total current liabilities 14.78M 16.91M 15.78M 16.61M 22.53M
Current deferred revenue 0.05M - - - -
Net debt 5.75M 6.11M 6.05M 6.14M 7.06M
Short term debt 0.46M - - - -
Short long term debt 0.38M 0.30M 0.55M 0.74M 0.90M
Short long term debt total 7.64M - - - -
Other stockholder equity 1.81M - 1.12M 0.02M 0.55M
Property plant equipment - - 9.75M 10.59M 12.26M
Total current assets 6.97M 9.71M 10.93M 12.45M 20.64M
Long term investments - - - - 0.00000M
Net tangible assets - - -1.43491M 0.06M 3.63M
Short term investments 0.00132M - - - -
Net receivables 1.22M 1.04M 1.73M 1.64M 3.30M
Long term debt 7.16M 6.53M 6.34M 6.33M 6.68M
Inventory 3.29M 7.18M 8.02M 7.85M 14.81M
Accounts payable 12.93M 15.43M 14.12M 14.75M 20.26M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.50M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 8.79M 10.07M 10.15M 11.23M 13.39M
Capital lease obligations 0.10M 0.18M - - -
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 0.01M -0.19735M -0.27675M -0.02644M 0.28M
Change to liabilities - - -0.64580M -5.38906M 7.94M
Total cashflows from investing activities - - -0.27675M -0.02644M 0.28M
Net borrowings - - 0.05M -0.51250M -1.37528M
Total cash from financing activities 0.45M -0.30902M -0.29803M -0.89962M -1.65996M
Change to operating activities - - 1.68M -0.39198M -0.40647M
Net income -2.10758M -2.92148M -2.82964M -3.70698M -12.44331M
Change in cash 1.17M -0.11669M -0.09453M 0.41M -0.97448M
Begin period cash flow 0.72M 0.84M 0.93M 0.52M 1.50M
End period cash flow 1.89M 0.72M 0.84M 0.93M 0.52M
Total cash from operating activities 0.68M 0.84M 0.27M 1.43M 0.71M
Issuance of capital stock - - - 0.00000M 0.25M
Depreciation 1.06M 1.11M 1.32M 1.84M 2.32M
Other cashflows from investing activities - - - - 0.52M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 3.89M 0.84M -0.17311M 6.96M -1.74353M
Change to account receivables -0.11940M 0.63M -0.08796M 1.66M 0.64M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.66015M -0.43922M -0.34970M -0.38712M -0.53418M
Change to netincome - - 1.00M 0.46M 0.10M
Capital expenditures 0.02M 0.20M 0.28M 0.08M 0.24M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.70M 2.44M 0.78M 2.84M 10.72M
Stock based compensation - 0.00000M 0.48M 0.00000M 0.00540M
Other non cash items 0.04M 0.21M 0.52M 0.46M 0.52M
Free cash flow 0.66M 0.63M -0.00570M 1.36M 0.47M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BGACF
BioNeutra Global Corporation		 - -% 0.07 - - 0.41 - 0.92 39.39
NSRGF
Nestle SA		 - -% 106.60 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR		 -0.42 0.39% 106.40 26.82 18.66 3.18 7.07 3.81 21.70
KHC
Kraft Heinz Co		 -0.205 0.77% 26.43 15.59 11.79 1.64 0.88 2.34 11.32
DANOY
Danone PK		 0.07 0.41% 17.08 28.42 16.39 1.44 2.23 1.85 12.41

Reports Covered

Stock Research & News

View All

Profile

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products, with a focus on oligosaccharides. The company offers isomaltooligosaccharide ingredients under the VitaFiber brand, that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.

BioNeutra Global Corporation

1030 West Georgia Street, Vancouver, BC, Canada, V6E 2Y3

Key Executives

Name Title Year Born
Dr. Jianhua Zhu Ph.D. Founder, CEO, Pres & Director NA
Mr. Yiyuan Jiang Chief Financial Officer NA
Mr. Ross Montagano Chief Operating Officer NA
Vinti Goel Ph.D. VP of Scientific & Regulatory Affairs NA
Sheri O'Brien VP of Sales & Marketing NA
Monica Barclay Corp. Sec. NA
Dr. Jianhua Zhu Ph.D. Founder, CEO, President & Director NA
Dr. Stephen C. Jakeway Ph.D. Chief Operating Officer NA
Vinti Goel Ph.D. Vice President of Scientific & Regulatory Affairs NA
Mr. Dario Mejia Vice President of Sales & Business Development NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.